505 related articles for article (PubMed ID: 27743148)
1. T-cell lymphomas, a challenging disease: types, treatments, and future.
Ma H; Abdul-Hay M
Int J Clin Oncol; 2017 Feb; 22(1):18-51. PubMed ID: 27743148
[TBL] [Abstract][Full Text] [Related]
2. SIE-SIES-GITMO guidelines for the management of adult peripheral T- and NK-cell lymphomas, excluding mature T-cell leukaemias.
Corradini P; Marchetti M; Barosi G; Billio A; Gallamini A; Pileri S; Pimpinelli N; Rossi G; Zinzani PL; Tura S
Ann Oncol; 2014 Dec; 25(12):2339-2350. PubMed ID: 24723488
[TBL] [Abstract][Full Text] [Related]
3. Treatment and prognosis of mature T-cell and NK-cell lymphoma: an analysis of patients with T-cell lymphoma treated in studies of the German High-Grade Non-Hodgkin Lymphoma Study Group.
Schmitz N; Trümper L; Ziepert M; Nickelsen M; Ho AD; Metzner B; Peter N; Loeffler M; Rosenwald A; Pfreundschuh M
Blood; 2010 Nov; 116(18):3418-25. PubMed ID: 20660290
[TBL] [Abstract][Full Text] [Related]
4. Effects of first-line chemotherapy on natural killer cells in adult T-cell leukemia-lymphoma and peripheral T-cell lymphoma.
Ogura M; Ishida T; Tsukasaki K; Takahashi T; Utsunomiya A
Cancer Chemother Pharmacol; 2016 Jul; 78(1):199-207. PubMed ID: 27289375
[TBL] [Abstract][Full Text] [Related]
5. Angioimmunoblastic T-Cell Lymphoma.
Broccoli A; Zinzani PL
Hematol Oncol Clin North Am; 2017 Apr; 31(2):223-238. PubMed ID: 28340875
[TBL] [Abstract][Full Text] [Related]
6. NK/T cell lymphoma associated with peripheral eosinophilia.
Yap E; Wan Jamaluddin WF; Tumian NR; Mashuri F; Mohammed F; Tan GC; Masir N; Abdul Wahid FS
Malays J Pathol; 2014 Dec; 36(3):201-5. PubMed ID: 25500520
[TBL] [Abstract][Full Text] [Related]
7. A multicenter trial of infusional etoposide, doxorubicin, and vincristine with cyclophosphamide and prednisone (EPOCH) in patients with relapsed non-Hodgkin's lymphoma.
Wilder DD; Ogden JL; Jain VK
Clin Lymphoma; 2001 Mar; 1(4):285-92. PubMed ID: 11707843
[TBL] [Abstract][Full Text] [Related]
8. Natural killer T-cell lymphoma of the tongue.
Cho KJ; Cho SG; Lee DH
Ann Otol Rhinol Laryngol; 2005 Jan; 114(1 Pt 1):55-7. PubMed ID: 15697163
[TBL] [Abstract][Full Text] [Related]
9. Peripheral T-cell lymphoma: the role of hematopoietic stem cell transplantation.
Gkotzamanidou M; Papadimitriou CA
Crit Rev Oncol Hematol; 2014 Feb; 89(2):248-61. PubMed ID: 24075060
[TBL] [Abstract][Full Text] [Related]
10. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
Hagemeister FB
Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
[TBL] [Abstract][Full Text] [Related]
11. Complete remission in advanced blastic NK-cell lymphoma/leukemia in elderly patients using the hyper-CVAD regimen.
Shapiro M; Wasik MA; Junkins-Hopkins JM; Rook AH; Vittorio CC; Itakura H; Frankel MC; Georgala S; Schuster SJ
Am J Hematol; 2003 Sep; 74(1):46-51. PubMed ID: 12949889
[TBL] [Abstract][Full Text] [Related]
12. Combined chemotherapy and external beam radiation for stage IE and IIE natural killer T-cell lymphoma of nasal cavity.
Wang B; Lu JJ; Ma X; Guo Y; Lu H; Hong X; Li J
Leuk Lymphoma; 2007 Feb; 48(2):396-402. PubMed ID: 17325902
[TBL] [Abstract][Full Text] [Related]
13. Treatment algorithms for mature T-cell and natural killer-cell neoplasms.
Tse E; Kwong YL
Future Oncol; 2011 Sep; 7(9):1101-12. PubMed ID: 21919697
[TBL] [Abstract][Full Text] [Related]
14. Autologous or allogeneic transplantation in B- and T-cell lymphomas.
Schmitz N; Nickelsen M; Glaß B
Best Pract Res Clin Haematol; 2012 Mar; 25(1):61-73. PubMed ID: 22409824
[TBL] [Abstract][Full Text] [Related]
15. High-dose therapy supported by autologous stem cell transplantation in patients with enteropathy-associated T-cell lymphoma.
Jantunen E; Juvonen E; Wiklund T; Putkonen M; Nousiainen T
Leuk Lymphoma; 2003 Dec; 44(12):2163-4. PubMed ID: 14959866
[No Abstract] [Full Text] [Related]
16. Update in T-cell lymphoma.
O'Connor OA
Clin Adv Hematol Oncol; 2010 Sep; 8(9):604-6. PubMed ID: 21157409
[No Abstract] [Full Text] [Related]
17. CD8+, CD56+ (natural killer-like) T-cell lymphoma involving the small intestine with no evidence of enteropathy: clinicopathology and molecular study of five Japanese patients.
Akiyama T; Okino T; Konishi H; Wani Y; Notohara K; Tsukayama C; Tsunoda T; Tasaka T; Masaki Y; Sugihara T; Sadahira Y
Pathol Int; 2008 Oct; 58(10):626-34. PubMed ID: 18801082
[TBL] [Abstract][Full Text] [Related]
18. Dose-adjusted EPOCH chemotherapy for untreated peripheral T-cell lymphomas: a multicenter phase II trial of West-JHOG PTCL0707.
Maeda Y; Nishimori H; Yoshida I; Hiramatsu Y; Uno M; Masaki Y; Sunami K; Masunari T; Nawa Y; Yamane H; Gomyo H; Takahashi T; Yano T; Matsuo K; Ohshima K; Nakamura S; Yoshino T; Tanimoto M
Haematologica; 2017 Dec; 102(12):2097-2103. PubMed ID: 28971899
[TBL] [Abstract][Full Text] [Related]
19. High-dose CHOP plus etoposide (MegaCHOEP) in T-cell lymphoma: a comparative analysis of patients treated within trials of the German High-Grade Non-Hodgkin Lymphoma Study Group (DSHNHL).
Nickelsen M; Ziepert M; Zeynalova S; Glass B; Metzner B; Leithaeuser M; Mueller-Hermelink HK; Pfreundschuh M; Schmitz N
Ann Oncol; 2009 Dec; 20(12):1977-84. PubMed ID: 19570965
[TBL] [Abstract][Full Text] [Related]
20. Anaplastic large cell lymphoma, ALK-positive.
Ferreri AJ; Govi S; Pileri SA; Savage KJ
Crit Rev Oncol Hematol; 2012 Aug; 83(2):293-302. PubMed ID: 22440390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]